TCTMD

Medtronic Finds TAVI with CoreValve® System Cost Effective for Treating Patients with Severe Aortic Stenosis

EuroPCR Presentation of "Real World" ADVANCE Study Confirms Economic Value of Novel Self-Expanding Valve in Patients Unable to Undergo Surgery PARIS -- Focused on offering devices that provide both ...
TCTMD

Medtronic Completes High Risk Patient Enrollment in CoreValve® U.S. Pivotal Trial and Gains FDA Approval to Study Intermediate Risk Patients in Global SURTAVI Trial

MINNEAPOLIS – Medtronic, Inc. has reached two clinical program milestones for its CoreValve® System in the United States. First, it completed enrollment in its study of high risk patients in its ...
Business Wire

Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) today announced it has completed patient enrollment in the extreme risk study in its CoreValve U.S. Pivotal Trial. The company also received ...
Business Wire

Medtronic to Appeal Jury Verdict in U.S. Patent Case Involving CoreValve ® Transcatheter Aortic Valve System

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), announced today that it will appeal the $73.5 million jury verdict returned in the U.S. District Court in Delaware deciding that the ...
Becker's Hospital Review

FDA Approves Medtronic’s CoreValve Transcatheter Without Panel Review

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s CoreValve Transcatheter for use without undergoing an independent device advisory panel review for the product, ...
Medscape

Cath Labs Should Use Both CoreValve and Sapien, Small Study Concludes

August 18, 2010 (Montreal, Quebec and Leicester, United Kingdom) — The best way to ensure that a patient who meets criteria for undergoing transcatheter aortic-valve replacement actually ends up ...
Orange County Business Journal

Analyst Weighs In on Medtronic’s Buy of CoreValve

Wall Street and others are continuing to weigh in on Medtronic Inc.’s pending $700 million buy of Irvine device maker CoreValve Inc. Medtronic, which employs some 550 people at its Santa Ana heart ...
Benzinga.com

Medtronic CEO On The Company's New Valve Product And How Covidien's Integration Is Progressing

"Well we are really excited about this product," Ishrak began. "This is an upgrade to our existing CoreValve transcatheter valve product. It makes the device repositionable and recapturable, which is ...
Orange County Business Journal

Growth Hurdle for Medtronic Boss; CoreValve Key?

The new chief executive of Medtronic Inc., the Minneapolis medical device maker with 700 Orange County workers, has a challenge on his hands. Omar Ishrak, a former executive at GE Healthcare Inc., was ...
Star Tribune

California jury renders $106.5 million verdict against Medtronic in heart-valve patent case

A federal jury in California said Wednesday that a unit of Medtronic must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement. After a seven-day trial in Santa Ana, Calif.
Yahoo

Medtronic hit with $106.5 million U.S. verdict in heart-valve patent case

(Reuters) - A unit of medical device maker Medtronic plc must pay $106.5 million to competitor Colibri Heart Valve LLC for patent infringement, a Santa Ana, California federal jury said Wednesday. The ...